Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy. Hwang YY, Chan TSY, Chan FHY, Lau CWP, et al. Ann Hematol 2022;101:1163-1172.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hwang YY, Chan TSY, Chan FHY, Lau CWP, et al. Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy. Ann Hematol 2022;101:1163-1172.
PMID: 35412083